Dapagliflozin Activates Neurons in the Central Nervous System and Regulates Cardiovascular Activity by Inhibiting SGLT-2 in Mice

PURPOSE: This study investigates the possible effect and central mechanism of novel antidiabetic medication sodium glucose transporter-2 (SGLT-2i) on the cardiovascular activity. MATERIAL AND METHODS: Thirty-four normal male C57BL/6 mice were randomly assigned to 2 groups to receive single Dapaglifl...

Descripción completa

Detalles Bibliográficos
Autores principales: Nguyen, Thiquynhnga, Wen, Song, Gong, Min, Yuan, Xinlu, Xu, Dongxiang, Wang, Chaoxun, Jin, Jianlan, Zhou, Ligang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7425107/
https://www.ncbi.nlm.nih.gov/pubmed/32848437
http://dx.doi.org/10.2147/DMSO.S258593

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7425107/
https://www.ncbi.nlm.nih.gov/pubmed/32848437
http://dx.doi.org/10.2147/DMSO.S258593

Ejemplares similares